Results 271 to 280 of about 213,470 (338)

Key Predictors of Relevant Weight Loss in Patients With Metabolic Dysfunction‐Associated Steatotic Liver Disease

United European Gastroenterology Journal, EarlyView.
ABSTRACT Background and Aims Weight loss is an effective therapeutic strategy for patients with metabolic dysfunction‐associated steatotic liver disease (MASLD). This study aimed to identify factors that predict relevant weight loss, defined as at least 7% of initial body weight, in MASLD outpatients.
Nicola Pugliese, Ivan Arcari, Federica Cerini, Rosa Lombardi, Federica Turati, Grazia Pennisi, Matteo Soleri, Simone Rocchetto, Diletta De Deo, Michele Sagasta, Chiara Masetti, Anna Ludovica Fracanzani, Salvatore Petta, Carlo La Vecchia, Mauro Viganò, Alessio Aghemo   +15 more
wiley   +1 more source

Effect of exercise on Fibroblast Growth Factor 21 levels in healthy males and females. [PDF]

PLoS One
Peterson M, Richardson KA, Funderburk L.
europepmc   +1 more source

Harbingers of change: Towards a mechanistic understanding of anticipatory plasticity in animal systems

Functional Ecology, EarlyView.
Read the free Plain Language Summary for this article on the Journal blog. Abstract Phenotypic plasticity is a strategy by which animals alter behaviour, morphology and/or physiology in response to cues of current conditions to cope with environmental heterogeneity.
Lauren Petrullo, Natalie J. Morris, Chloé Tharin, Ben Dantzer   +3 more
wiley   +1 more source

RNA-binding proteins: a novel target for modulating glucose and lipid metabolism. [PDF]

Signal Transduct Target Ther
Hu Y, Sun Q.
europepmc   +1 more source

The Long Arc of Substance Use Policy Innovation in Medicaid: Looking Back, Looking Forward

The Milbank Quarterly, EarlyView.
Policy Points The role of Medicaid in financing, organizing, and delivering substance use disorder (SUD) treatment has grown tremendously over time owing to expansions of eligibility and a push toward more uniformity in benefits. Current innovations in SUD treatment focus on expanding the delivery system to create a comprehensive continuum of care ...
BRENDAN SALONER
wiley   +1 more source

Emerging Treatments for Obesity: the Role of GLP1 Receptor Agonists on Stroke. [PDF]

Curr Neurol Neurosci Rep
Mariscal M, Testai FD.
europepmc   +1 more source

Aspirin, Birthweight, and Large‐For‐Gestational‐Age Neonates: A Secondary Analysis of the ASPRE Trial

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective To investigate the effects of aspirin on the distribution of birthweight and its impact on the rates of large‐for‐gestational‐age (LGA) neonates. Design Secondary analysis of the Combined Multimarker Screening and Randomised Patient Treatment with Aspirin for Evidence‐based Preeclampsia Prevention (ASPRE) trial.
Daniel L. Rolnik, Liona C. Poon, Argyro Syngelaki, David Wright, Neil O'Gorman, Catalina de Paco Matallana, Ranjit Akolekar, Deepa Janga, Mandeep Singh, Francisca S. Molina, Nicola Persico, Jacques C. Jani, Walter Plasencia, George Papaioannou, Kinneret Tenenbaum‐Gavish, Hamutal Meiri, Kypros H. Nicolaides   +16 more
wiley   +1 more source

Therapeutic horizons in metabolic dysfunction-associated steatohepatitis. [PDF]

J Clin Invest
Newsome PN, Loomba R.
europepmc   +1 more source

SGLT2 Inhibition by Enavogliflozin Significantly Reduces Aβ Pathology and Restores Cognitive Function via Upregulation of Microglial AMPK Signaling in 5XFAD Mouse Model of Alzheimer's Disease

Aging Cell, EarlyView.
SGLT2 inhibition with Enavogliflozin significantly improves cognitive function and reduces Aβ pathology in the 5XFAD mouse model of Alzheimer's disease. Through AMPK activation, Enavogliflozin enhances microglial mitochondrial function and Aβ phagocytosis while reducing neuroinflammation.
Jihui Han, Jaehoon Song, Eun Sun Jung, Ji Won Choi, Hye Young Ji, Inhee Mook‐Jung   +5 more
wiley   +1 more source

Blockade of glucagon receptor induces α-cell hypersecretion by hyperaminoacidemia in mice. [PDF]

Nat Commun
Jia J, Bai X, Kang Q, Jiang F, Wong FS, Jin Q, Li M.   +6 more
europepmc   +1 more source